骨髓增生异常综合征中国诊断与治疗威廉亚洲博彩公司 (2019年)

2019-02-20 中华医学会血液学分会 中华血液学杂志.2019,40(2):89-97.

骨髓增生异常综合征(myelodysplastic syndromes,MDS)是一组起源于造血干细胞的异质性髓系克隆性疾病,其特点是髓系细胞发育异常,表现为无效造血、难治性血细胞减少,高风险向急性髓系白血病(AML)转化。为进一步提高和规范我国MDS的诊治水平,中华医学会血液学分会结合近年来MDS领域的最新临床研究成果和国内的实际情况,制订了《骨髓增生异常综合征中国诊断与治疗威廉亚洲博彩公司 (2019年版)

中文标题:

骨髓增生异常综合征中国诊断与治疗威廉亚洲博彩公司 (2019年)

发布日期:

2019-02-20

简要介绍:

骨髓增生异常综合征(myelodysplastic syndromes,MDS)是一组起源于造血干细胞的异质性髓系克隆性疾病,其特点是髓系细胞发育异常,表现为无效造血、难治性血细胞减少,高风险向急性髓系白血病(AML)转化。为进一步提高和规范我国MDS的诊治水平,中华医学会血液学分会结合近年来MDS领域的最新临床研究成果和国内的实际情况,制订了《骨髓增生异常综合征中国诊断与治疗威廉亚洲博彩公司 (2019年版)》。 、


拓展威廉亚洲博彩公司 :骨髓增生异常综合征相关威廉亚洲博彩公司 :

下载附件:

(因为版权问题,不支持下载)

评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1058629, encodeId=47cb10586296d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Fri Oct 08 15:01:20 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052539, encodeId=ff07105253933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:50:25 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010056, encodeId=f557101005635, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/a0aa0df9c66975052d7377d3b64e5797.jpg, createdBy=86665210471, createdName=丙泊酚的米, createdTime=Sat Aug 21 15:15:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008846, encodeId=154f100884674, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e0b1492227, createdName=568821, createdTime=Tue Aug 17 22:17:45 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999718, encodeId=af84999e1859, content=xuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Thu Jul 15 12:46:11 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-10-08 付星

    学习学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1058629, encodeId=47cb10586296d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Fri Oct 08 15:01:20 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052539, encodeId=ff07105253933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:50:25 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010056, encodeId=f557101005635, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/a0aa0df9c66975052d7377d3b64e5797.jpg, createdBy=86665210471, createdName=丙泊酚的米, createdTime=Sat Aug 21 15:15:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008846, encodeId=154f100884674, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e0b1492227, createdName=568821, createdTime=Tue Aug 17 22:17:45 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999718, encodeId=af84999e1859, content=xuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Thu Jul 15 12:46:11 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-09-18 ms8000000981268929

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1058629, encodeId=47cb10586296d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Fri Oct 08 15:01:20 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052539, encodeId=ff07105253933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:50:25 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010056, encodeId=f557101005635, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/a0aa0df9c66975052d7377d3b64e5797.jpg, createdBy=86665210471, createdName=丙泊酚的米, createdTime=Sat Aug 21 15:15:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008846, encodeId=154f100884674, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e0b1492227, createdName=568821, createdTime=Tue Aug 17 22:17:45 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999718, encodeId=af84999e1859, content=xuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Thu Jul 15 12:46:11 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-08-21 丙泊酚的米

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1058629, encodeId=47cb10586296d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Fri Oct 08 15:01:20 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052539, encodeId=ff07105253933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:50:25 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010056, encodeId=f557101005635, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/a0aa0df9c66975052d7377d3b64e5797.jpg, createdBy=86665210471, createdName=丙泊酚的米, createdTime=Sat Aug 21 15:15:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008846, encodeId=154f100884674, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e0b1492227, createdName=568821, createdTime=Tue Aug 17 22:17:45 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999718, encodeId=af84999e1859, content=xuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Thu Jul 15 12:46:11 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-08-17 568821

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1058629, encodeId=47cb10586296d, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Fri Oct 08 15:01:20 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052539, encodeId=ff07105253933, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de925411438, createdName=ms8000000981268929, createdTime=Sat Sep 18 11:50:25 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010056, encodeId=f557101005635, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/25/a0aa0df9c66975052d7377d3b64e5797.jpg, createdBy=86665210471, createdName=丙泊酚的米, createdTime=Sat Aug 21 15:15:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008846, encodeId=154f100884674, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e0b1492227, createdName=568821, createdTime=Tue Aug 17 22:17:45 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999718, encodeId=af84999e1859, content=xuexi, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5185543565, createdName=ms4000000408264698, createdTime=Thu Jul 15 12:46:11 CST 2021, time=2021-07-15, status=1, ipAttribution=)]
    2021-07-15 ms4000000408264698

    xuexi

    0